{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:27:57Z","timestamp":1791581277952,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017959","name":"Health Commission of Hebei Province","doi-asserted-by":"publisher","award":["21377760D"],"award-info":[{"award-number":["21377760D"]}],"id":[{"id":"10.13039\/100017959","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017959","name":"Health Commission of Hebei Province","doi-asserted-by":"publisher","award":["20230442"],"award-info":[{"award-number":["20230442"]}],"id":[{"id":"10.13039\/100017959","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018806","name":"Department of Science and Technology of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008238","name":"Hebei Province Department of Science And Technology","doi-asserted-by":"publisher","award":["H2021206377"],"award-info":[{"award-number":["H2021206377"]}],"id":[{"id":"10.13039\/501100008238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ygyno.2024.04.013","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T06:34:29Z","timestamp":1714458869000},"page":"154-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment"],"prefix":"10.1016","volume":"186","author":[{"given":"Hongfa","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengfang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.04.013_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/IGC.0000000000000669","article-title":"Management of Endometrial Hyperplasia with a Levonorgestrel-releasing intrauterine system: a Korean gynecologic-oncology group study","volume":"26","author":"Kim","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111825","article-title":"Fertility-sparing approach in women affected by stage I and low-grade endometrial carcinoma: an updated overview","volume":"22","author":"Gullo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212248","article-title":"Fertility sparing treatments in endometrial cancer patients: the potential role of the new molecular classification","volume":"22","author":"Cavaliere","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0020","first-page":"13","article-title":"Molecular classification to prognosticate response in medically managed endometrial cancers and endometrial intraepithelial neoplasia","author":"Puechl","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"370","key":"10.1016\/j.ygyno.2024.04.013_bb0025","first-page":"e1","article-title":"Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer","volume":"224","author":"Chung","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0030","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","article-title":"European Society of Gynecological Oncology Task Force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients","volume":"25","author":"Rodolakis","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1746-1596-9-126","article-title":"Heterogenous mismatch-repair status in colorectal cancer","volume":"9","author":"Joost","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0040","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0045","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","article-title":"The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis","volume":"21","author":"Ryan","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2019.03.098","article-title":"Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma","volume":"153","author":"Britton","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0055","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.2016.67.8722","article-title":"Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology\/gynecologic oncology group study","volume":"34","author":"McMeekin","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0060","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/1471-0528.14491","article-title":"Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series","volume":"124","author":"Zakhour","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2015.02.028","article-title":"Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors","volume":"138","author":"Burleigh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0070","first-page":"23","article-title":"Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial Cancer patients: current evidence and future directions","author":"Contreras","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ygyno.2021.03.029","article-title":"Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: a multi-center study","volume":"161","author":"Raffone","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154278","article-title":"Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia","volume":"241","author":"Zhang","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0085","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027961","article-title":"Fertility-preserving treatment in patients with early-stage endometrial cancer: a protocol for systematic review and meta-analysis","volume":"100","author":"Zhao","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"266","key":"10.1016\/j.ygyno.2024.04.013_bb0095","first-page":"e1","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0100","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ijgc-2018-000081","article-title":"Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia","volume":"29","author":"Wang","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/ajcp\/aqab100","article-title":"Endometrial Cancer characteristics and risk of recurrence","volume":"157","author":"Borden","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0125","first-page":"59","article-title":"Fertility preservation in endometrial cancer-treatment and molecular aspects","author":"Schubert","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/IGC.0000000000000421","article-title":"Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia","volume":"25","author":"Zauber","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/IGC.0000000000000421","article-title":"Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia","volume":"25","author":"Zauber","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jmig.2017.07.022","article-title":"Updates on conservative Management of Endometrial Cancer","volume":"25","author":"Corzo","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0155","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2024.04.013_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2022.01.007","article-title":"Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment","volume":"164","author":"Leon-Castillo","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0175","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: pooled data about prognosis","volume":"155","author":"Raffone","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0180","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2024.04.013_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","article-title":"BGCS uterine cancer guidelines: recommendations for practice","volume":"213","author":"Sundar","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:20:50Z","timestamp":1778714450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824001987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":38,"alternative-id":["S0090825824001987"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}